Clinical trials in Belarus
366 studies list at least one site in Belarus. 34 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-23.
Status
- Completed
- 243
- Status unknown
- 35
- Active, not recruiting
- 30
- Recruiting
- 27
- Terminated
- 21
- Enrolling by invitation
- 4
Phase
- Phase 3
- 208
- Phase 2
- 87
- Phase 1
- 40
- Phase 4
- 10
- Early Phase 1
- 2
Most studied here
Who runs them
Sanofi (21) · Biocad (20) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (20) · Actelion (14) · AbbVie (13) · Celgene (8) · Belarusian State Medical University (7) · Hoffmann-La Roche (6)
Studies
Recruiting first, then most recently updated. Showing 50 of 366 — search for more.
- Mesenteric Ischemia Markers StudyRecruitingNCT07460700Not applicable
- Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in BelarusRecruitingNCT07288515
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaRecruitingNCT01949129Phase 2/3
- A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
- LANDMARK Trial: a Randomised Controlled Trial of Myval THVRecruitingNCT04275726Not applicable
- Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.RecruitingNCT06762431Phase 1/2
- A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)RecruitingNCT07742215Phase 3
- Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus ErythematosusEnrolling by invitationNCT07720310
- A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular DystrophyRecruitingNCT07673809Phase 1/2
- Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A PatientsRecruitingNCT03695978
- PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical CancerRecruitingNCT07472153Phase 2/3
- Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell LymphomaRecruitingNCT07524816
- Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple MyelomaRecruitingNCT07477912Phase 1/2
- PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal CancerRecruitingNCT07472140Phase 2/3
- Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate CancerRecruitingNCT07308990Not applicable
- Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep LearningRecruitingNCT05800821
- Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register DataEnrolling by invitationNCT07159698
- This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Not yet recruitingNCT07162571Phase 1/2
- BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast CancerRecruitingNCT07108309Phase 2
- Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound ProcessNot yet recruitingNCT06232421Phase 2/3
- An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-IIRecruitingNCT06232434Phase 2/3
- Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)RecruitingNCT06120582Phase 1/2
- Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous VeinsRecruitingNCT06971068Not applicable
- Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/VulvovaginitisRecruitingNCT06835361Phase 2/3
- Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/LymphomaRecruitingNCT05333302Phase 1
- Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AMLRecruitingNCT05272293Phase 1/2
- Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AMLRecruitingNCT05334693Phase 1/2
- EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVEnrolling by invitationNCT02699736
- Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)RecruitingNCT05747261Phase 1/2
- International Chronic Myeloid Leukemia Pediatric StudyRecruitingNCT01281735
- Allergy Diagnostic Test Based on Microchip TechnologyNot yet recruitingNCT06167564Not applicable
- Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisRecruitingNCT04878003Phase 2
- A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic AnemiaEnrolling by invitationNCT04138927Phase 3
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)RecruitingNCT03390387Not applicable
- An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisActive, not recruitingNCT04130997Phase 3
- A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)Active, not recruitingNCT04497844Phase 3
- Determination of the Optimal Treatment Target in Ulcerative ColitisCompletedNCT04259138Phase 4
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT03466411Phase 2/3
- Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionActive, not recruitingNCT04273945Phase 3
- A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial HypertensionActive, not recruitingNCT03492177Phase 2
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionActive, not recruitingNCT04175600Phase 3
- A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial CancerActive, not recruitingNCT03473743Phase 1/2
- Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian CancerCompletedNCT05979298Phase 2
- A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseActive, not recruitingNCT03105102Phase 3
- A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMSCompletedNCT04121221Phase 3
- Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusCompletedNCT02472795Phase 1/2
- A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisActive, not recruitingNCT05269004Phase 3
- A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerActive, not recruitingNCT03456076Phase 3
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03950232Phase 3
- Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)CompletedNCT01947907Phase 2